2017
DOI: 10.1161/strokeaha.117.018675
|View full text |Cite
|
Sign up to set email alerts
|

Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease

Abstract: Background and Purpose It is currently unclear whether midlife systemic inflammation promotes the development of white matter (WM) abnormalities and small vessel disease in the elderly. We examined the association of midlife systemic inflammation with late-life white matter hyperintensity (WMH) volume, deep and periventricular WM microstructural integrity (fractional anisotropy [FA], mean diffusivity [MD]), cerebral infarcts and microbleeds in a biracial prospective cohort study. Methods Linear and logistic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
83
2
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(91 citation statements)
references
References 26 publications
4
83
2
2
Order By: Relevance
“…The progressive, silent development of cerebral small vessel disease necessitates the development of alternative methods for identifying those at risk. In population studies, mid-life vascular risk factors increase the risk of white matter injury resulting from cSVD [17]. However, the identification of biomarkers to assist in separating those with concurrent vascular risk factors yet no brain injury from those with vascular risk factors who already have evidence of pathology from cerebral small vessel disease is critical to developing therapeutic strategies to stem this growing public health challenge.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The progressive, silent development of cerebral small vessel disease necessitates the development of alternative methods for identifying those at risk. In population studies, mid-life vascular risk factors increase the risk of white matter injury resulting from cSVD [17]. However, the identification of biomarkers to assist in separating those with concurrent vascular risk factors yet no brain injury from those with vascular risk factors who already have evidence of pathology from cerebral small vessel disease is critical to developing therapeutic strategies to stem this growing public health challenge.…”
Section: Discussionmentioning
confidence: 99%
“…High levels of chronic inflammation resulting from systemic vascular risk factors such as hypertension and diabetes are proposed to exacerbate cSVD by damaging cerebral endothelia. A number of systemic inflammatory indicators have been implicated in cSVD [17,18], yet do not coalesce around a specific molecular pathway. In this study, we aimed to investigate the association of a biologically interconnected network of systemic inflammatory markers centered on the pleiotropic pro-inflammatory cytokine IL-18 with sCVD burden.…”
Section: Introductionmentioning
confidence: 99%
“…Bununla birlikte, mikrovasküler reperfüzyon her zaman gerçekleştirilemez, hastaların tamamı endovasküler tedaviden fayda sağlamayabilir ve hastaların çoğu da reperfüzyon tedavileri için uygun değildir. (106). İnme, sitokinler, vazoaktif maddeler, alarminler ve akut faz proteinleri de dahil olmak üzere, çözünür medyatörleri ve nöral sinyalleri barındıran çok fazlı bir sistemik enflamatuar yanıtı tetiklemekte olup, ardından immün yanıtlar inhibe edildiğinden inme sonrası enfeksiyon riski artmaktadır.…”
Section: öNemli Translasyonel Araştırma Konularıunclassified
“…Nevertheless, systemic inflammation may contribute to the pathogenesis of WMH in the elder population in a recent prospective study involving a large sample size. This implied that systemic inflammation was correlated with the progression of CSVD, especially in the conditions with persistent inflammation [17].…”
Section: Moreover No Correlation Was Noticed Between Serum Lp-pla2 Amentioning
confidence: 94%